| Marshall Urist |
|
Royalty Pharma plc |
Executive VP and Head of Research & Investments |
Biotechnology: Pharmaceutical Preparations |
|
United States |
| Arthur McGivern |
|
Royalty Pharma plc |
Executive Vice President of Investments & General Counsel |
Biotechnology: Pharmaceutical Preparations |
|
United States |
| Ashwin Ashwin |
|
Royalty Pharma plc |
Executive Vice President of Investments |
Biotechnology: Pharmaceutical Preparations |
|
United States |
| Kristin Stafford |
|
Royalty Pharma plc |
Senior VP & Chief Accounting Officer |
Biotechnology: Pharmaceutical Preparations |
|
United States |
| Eric Schneider |
|
Royalty Pharma plc |
Senior VP & Chief Technology Officer |
Biotechnology: Pharmaceutical Preparations |
|
United States |
| James Reddoch |
|
Royalty Pharma plc |
Executive VP of Investments & Chief Scientific Officer |
Biotechnology: Pharmaceutical Preparations |
|
United States |
| Gregory Smith |
gre**********@teradyne.com
|
Teradyne |
President, CEO & Director |
Manufacturing |
|
United States |
| Charles Gray |
cha*********@teradyne.com
|
Teradyne |
VP, General Counsel & Secretary |
Manufacturing |
|
United States |
| Richard Burns |
ric**********@teradyne.com
|
Teradyne |
President of Semiconductor Test Division |
Manufacturing |
|
United States |
| Timothy Moriarty |
tim*************@teradyne.com
|
Teradyne |
Vice President of Corporate Development |
Manufacturing |
|
United States |